World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
46
Citations
10621
World Ranking
18848
National Ranking
7701

Alexey Lugovskoy publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Alexey Lugovskoy sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 413 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 848 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 949 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 840 scientists 207–216 publications: 733 scientists 217–226 publications: 708 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 417 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 196 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 59 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 111 publications — 9th percentile

9% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Alexey Lugovskoy D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Alexey Lugovskoy sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 316 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 899 scientists 52–53 D-Index: 1,025 scientists 54–55 D-Index: 1,149 scientists 56–57 D-Index: 1,235 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,162 scientists 62–63 D-Index: 1,130 scientists 64–65 D-Index: 1,031 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 714 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 71 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 46 D-Index — 4th percentile

4% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Alexey Lugovskoy is affiliated with Biogen in the United States. Their research spans multiple fields including medicine and engineering, specifically focusing on key subfields such as radiology, nuclear medicine and imaging, oncology, and biomedical engineering.

The scientist's work covers several main topics, notably in monoclonal and polyclonal antibodies research, CAR-T cell therapy research, and nanofabrication and lithography techniques. These topics reflect a cross-disciplinary approach involving both biological and engineering aspects relevant to therapeutic development and medical technology.

Lugovskoy has contributed to scientific literature with publications appearing in venues such as mAbs. A recent example is their 2022 paper titled "Development of disulfide-stabilized Fabs for targeting of antibody-directed nanotherapeutics", published in mAbs.

The scientist has collaborated frequently with several co-authors, including:

  • Melissa L. Geddie
  • Dmitri B. Kirpotin
  • Neeraj Kohli
  • Tad Kornaga
  • Bjoern Boll

Their research intersects innovative therapies and nanotechnology approaches, reflecting an emphasis on antibody design and delivery systems. The integration of cancer immunotherapy research, particularly CAR-T cell therapy, with nanofabrication techniques suggests focus areas targeting therapeutic precision and efficacy.

Publications in multiple fields and topics indicate a multifaceted expertise bridging clinical applications and technological development. The combination of oncology-related research with biomedical engineering principles confirms involvement in translational science efforts.

No awards or book publications have been listed in connection with their career to date.

Best Publications

  • Identification of RIP1 kinase as a specific cellular target of necrostatins.

    Alexei Degterev;Junichi Hitomi;Megan Germscheid;Irene L Ch'en

  • Identification of small-molecule inhibitors of interaction between the BH3 domain and Bcl-xL.

    Alexei Degterev;Alexey Lugovskoy;Michael Cardone;Bradley Mulley

  • The PHD Finger of the Chromatin-Associated Protein ING2 Functions as a Nuclear Phosphoinositide Receptor

    Or Gozani;Philip Karuman;David R. Jones;Dmitri Ivanov

  • Small-Molecule Inhibition of TNF-α

    Molly M. He;Annemarie Stroustrup Smith;Johan D. Oslob;William M. Flanagan

  • Ribosome Loading onto the mRNA Cap Is Driven by Conformational Coupling between eIF4G and eIF4E

    John D. Gross;Nathan J. Moerke;Tobias von der Haar;Alexey A. Lugovskoy

  • Proteome-wide analysis in Saccharomyces cerevisiae identifies several PHD fingers as novel direct and selective binding modules of histone H3 methylated at either lysine 4 or lysine 36.

    Xiaobing Shi;Ioulia Kachirskaia;Kay L. Walter;Jen Hao A. Kuo

  • Identification and Characterization of Mefloquine Efficacy against JC Virus In Vitro

    Margot Brickelmaier;Alexey Lugovskoy;Ramya Kartikeyan;Marta M. Reviriego-Mendoza

  • Stabilized polypeptide compositions

    Stephen Demarest;Scott Glaser;Brian Robert Miller;Xiufeng Wu

  • Small molecules inhibit the interaction of Nrf2 and the Keap1 Kelch domain through a non-covalent mechanism.

    Douglas Marcotte;Weike Zeng;Jean-Christophe Hus;Andres McKenzie

  • Affinity enhancement of an in vivo matured therapeutic antibody using structure-based computational design

    Louis A. Clark;P. Ann Boriack-Sjodin;John Eldredge;Christopher Fitch

  • A solubility-enhancement tag (SET) for NMR studies of poorly behaving proteins.

    Pei Zhou;Alexey A. Lugovskoy;Gerhard Wagner

  • Processing of Anti-Müllerian Hormone Regulates Receptor Activation by a Mechanism Distinct from TGF-β

    Nathalie di Clemente;Soazik P. Jamin;Alexey Lugovskoy;Paul Carmillo

  • Progressive Multifocal Leukoencephalopathy (PML) Development Is Associated With Mutations in JC Virus Capsid Protein VP1 That Change Its Receptor Specificity

    Leonid Gorelik;Carl Reid;Manuela Testa;Margot Brickelmaier

  • Small molecule inhibition of phosphatidylinositol-3,4,5-triphosphate (PIP3) binding to pleckstrin homology domains

    Benchun Miao;Igor Skidan;Jinsheng Yang;Alexey Lugovskoy

  • A novel approach for characterizing protein ligand complexes: molecular basis for specificity of small-molecule Bcl-2 inhibitors.

    Alexey A Lugovskoy;Alexei I Degterev;Amr F Fahmy;Pei Zhou

  • Structure of a NEMO/IKK-Associating Domain Reveals Architecture of the Interaction Site.

    Mia Rushe;Laura Silvian;Sarah Bixler;Ling Ling Chen

  • Identification of a new murine tumor necrosis factor receptor locus that contains two novel murine receptors for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).

    Pascal Schneider;Dian Olson;Aubry Tardivel;Beth Browning

  • Adaptive Mutations in the JC Virus Protein Capsid Are Associated with Progressive Multifocal Leukoencephalopathy (PML)

    Shamil R. Sunyaev;Shamil R. Sunyaev;Alexey Lugovskoy;Kenneth Simon;Leonid Gorelik

  • Anti-tumor activity of stability-engineered IgG-like bispecific antibodies targeting TRAIL-R2 and LTbetaR.

    Jennifer S. Michaelson;Stephen J. Demarest;Brian Miller;Aldo Amatucci

  • Proteome-wide Analysis in Saccharomyces cerevisiae Identifies Several PHD Fingers as Novel Direct and Selective Binding Modules of Histone H3 Methylated at

    Xiaobing Shi;Ioulia Kachirskaia;Kay L. Walter;Jen-Hao A. Kuo

Frequent Co-Authors

R. Blake Pepinsky
R. Blake Pepinsky Biogen (United States)
Gerhard Wagner
Gerhard Wagner Harvard University
Paul H. Weinreb
Paul H. Weinreb Biogen (United States)
Linda C. Burkly
Linda C. Burkly Biogen (United States)
Junying Yuan
Junying Yuan Harvard University
James D. Marks
James D. Marks University of California, San Francisco
Or Gozani
Or Gozani Stanford University
Shamil R. Sunyaev
Shamil R. Sunyaev Harvard University
Paul D. Rennert
Paul D. Rennert Biogen (United States)
Alain Beck
Alain Beck University of Strasbourg

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Biology and Biochemistry opens doors to a variety of healthcare careers. Fields like medical billing and coding are expanding rapidly, offering both flexibility and strong earning potential. You can discover typical medical coding salary ranges and what to expect as you explore this path.

The medical billing and coding job outlook is positive, with increasing demand for skilled professionals. Online programs make it easier to get qualified for these roles without disrupting your schedule or location.

If you’re interested in data, an online health information management degree could be a good fit. This degree prepares you for important roles handling patient data and technology in healthcare systems.

For those drawn to health and wellness, a nutrition masters online can lead to careers in food science, public health, and clinical nutrition. These flexible, affordable options help you advance your education and career on your terms.

Best Scientists Citing Alexey Lugovskoy

Trending Scientists